Suppr超能文献

miR-7-5p 在集落形成单位-山顶集落中的解码作为亚临床心血管疾病的生物标志物-MERIT 研究。

Decoding of miR-7-5p in Colony Forming Unit-Hill Colonies as a Biomarker of Subclinical Cardiovascular Disease-A MERIT Study.

机构信息

Biochemistry Department, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

出版信息

Int J Mol Sci. 2023 Jul 26;24(15):11977. doi: 10.3390/ijms241511977.

Abstract

Colony forming unit-Hill (CFU-Hill) colonies were established to serve as a sensitive biomarker for vascular health. In animals, the overexpression of miR-7-5p was shown to be pro-atherogenic and associated with increased cardiovascular disease (CVD) risk. In a MERIT study, we aimed to explore the role of miR-7-5p expression in CFU-Hill colonies in type 1 diabetes mellitus (T1DM) and the effect of metformin in subclinical CVD. The expression of miR-7-5p in CFU-Hill colonies in 29 T1DM subjects without CVD and 20 healthy controls (HC) was measured. Metformin was administered to T1DM subjects for eight weeks. MiR-7-5p was upregulated in T1DM whereas metformin reduced it to HC levels. MiR-7-5p was positively correlated with c-reactive protein, and C-X-C motif chemokine ligand 10. The receiver operating characteristic curve revealed miR-7-5p as a biomarker of CVD, and upregulated miR-7-5p, defining subclinical CVD at a HbA1c level of 44.3 mmol/mol. Ingenuity pathway analysis predicted miR-7-5p to inhibit the mRNA expression of Krüppel-like factor 4, epidermal growth factor receptor, insulin-like growth factor 1 receptor, v-raf-1 murine leukemia viral oncogene homolog 1 and insulin receptor substrate ½, and insulin receptor, while metformin activated these miRNAs via transforming growth factor-β1 and Smad2/3. We proved the pro-atherogenic effect of miR-7-5p that maybe used as a prognostic biomarker.

摘要

集落形成单位-希尔(CFU-Hill)集落被确立为血管健康的敏感生物标志物。在动物中,miR-7-5p 的过表达被证明具有促动脉粥样硬化作用,并与增加心血管疾病(CVD)风险相关。在一项 MERIT 研究中,我们旨在探讨 miR-7-5p 在 1 型糖尿病(T1DM)中 CFU-Hill 集落中的表达及其在亚临床 CVD 中二甲双胍的作用。在 29 名无 CVD 的 T1DM 患者和 20 名健康对照(HC)中测量了 CFU-Hill 集落中 miR-7-5p 的表达。T1DM 患者接受二甲双胍治疗八周。miR-7-5p 在 T1DM 中上调,而二甲双胍将其降低至 HC 水平。miR-7-5p 与 C 反应蛋白和 C-X-C 基序趋化因子配体 10 呈正相关。ROC 曲线显示 miR-7-5p 是 CVD 的生物标志物,上调的 miR-7-5p 在 HbA1c 水平为 44.3mmol/mol 时定义为亚临床 CVD。Ingenuity 通路分析预测 miR-7-5p 抑制 Krüppel 样因子 4、表皮生长因子受体、胰岛素样生长因子 1 受体、v-raf-1 鼠白血病病毒致癌基因同源物 1 和胰岛素受体底物 1/2 和胰岛素受体的 mRNA 表达,而二甲双胍通过转化生长因子-β1 和 Smad2/3 激活这些 miRNA。我们证明了 miR-7-5p 的促动脉粥样硬化作用,它可能作为一种预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66c/10418446/4a997a7cd2bf/ijms-24-11977-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验